Open access
3,369
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
Ana Antunesa MabDesign, Lyon, FranceView further author information
, Luis Alvarez-Vallinab Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain;c H120-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Centre (CNIO), Madrid, SpainView further author information
, Federico Bertogliod Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics, Department of Biotechnology, Braunschweig, Germany, Current addressView further author information
, Nicolas Bouquine REGIMBEAU, Paris – 69006 Lyon, FranceView further author information
, Stéphanie Cornenf Innate Pharma, Marseille, FranceView further author information
, Francis Duffieuxg Large Molecules Research, Sanofi, Vitry-Sur-Seine, FranceView further author information
, Pierre Ferréh Compugen Ltd, Holon, IsraelView further author information
, Raphaëlle Gillete REGIMBEAU, Paris – 69006 Lyon, FranceView further author information
, Christian Jorgenseni IRMB, université de Montpellier, Inserm U1183, Montpellier, France;j Unité d’immunologie clinique et de thérapeutique des maladies ostéoarticulaires, département de rhumatologie, hôpital Lapeyronie, Montpellier, FranceView further author information
, Mark B Leickk Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USAView further author information
, Bernard Maillèrel Université de Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette, FranceView further author information
, Hélène Negrem Institut de Recherches Internationales Servier, Suresnes, FranceView further author information
, Mireia Pelegrinn IRMB, Univ Montpellier, INSERM, CNRS, Montpellier, FranceView further author information
, Nicolas Poiriero OSE Immunotherapeutics, Nantes, FranceView further author information
, Dietmar Reuschp Pharma Technical Development Analytics Biologics, Roche Diagnostics GmbH, Penzberg, GermanyView further author information
, Bruno Robertq IRCM, INSERM, U1194 Univ Montpellier, ICM, 208, rue des Apothicaires, Montpellier, France
https://orcid.org/0000-0001-5573-6945View further author information
Guy Serrer Institut Toulousain des maladies infectieuses et inflammatoires - INFINITY- Inserm, CNRS, Université Toulouse III, Toulouse, FranceView further author information
, Alain Vicaris Calypso Biotech SA, Plan-les-Ouates, SwitzerlandView further author information
, Martin Villalban IRMB, Univ Montpellier, INSERM, CNRS, Montpellier, FranceView further author information
, Christoph Volperst Michalski Huettermann & Partner, Frankfurt/Main, GermanyView further author information
, Gavin Vuddamalaya MabDesign, Lyon, FranceView further author information
, Hervé Watieru CEPR, INSERM U1100 Université de Tours, et CHU de Tours, Tours cedex, FranceView further author information
, Thierry Wurchv Evotec, Toulouse, FranceView further author information
, Lennart Zabeauw Orionis Biosciences BV, Ghent, BelgiumView further author information
, Stefan Zielonkax Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, GermanyView further author information
, Baolin Zhangy Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USAView further author information
, Alain Beckz Biologics CMC & Developability, Institut de Recherche Pierre Fabre, St Julien-en-Genevois Cedex, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-4725-1777View further author information
Pierre Martineauq IRCM, INSERM, U1194 Univ Montpellier, ICM, 208, rue des Apothicaires, Montpellier, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-7993-7183View further author information
Article: 2211692
|
Received 31 Mar 2023, Accepted 04 May 2023, Published online: 15 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.